Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Journal of thrombosis and thrombolysis - 1 Jun 2008

Rahimi Zohreh, Vaisi-Raygani Asad, Nagel Ronald L, Muniz Adriana

Abstract excerpt

BACKGROUND: A hypercoagulable state in sickle cell disease (SCD) and beta thalassemia has been established and thrombosis is an important aspect of the clinical spectrum of sickle cell disease. In a case-control study, the prevalence of factor V Leiden and prothrombin G20210A mutations were investigated among SCD patients from Southern Iran. METHODS: Patients comprised 60 individuals with SCD; of them 35 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to beta-Thalassemia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Coagulation

Share to Factor V

Share to Prothrombin

Share to Sickle Cell Trait

Share to Thrombophilia

Source

Identifiers

PMID: 17619828
DOI: 10.1007/s11239-007-0069-x

Genes

SCD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.PMID 17619828Read ↗

Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.Semantic proximity Read ↗

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.Semantic proximity Read ↗

Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.Semantic proximity Read ↗

Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.Semantic proximity Read ↗

Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran.Semantic proximity Read ↗

Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil.Semantic proximity Read ↗

Interplay Between Sickle Cell Disease and Thrombosis: Pathophysiology and Potential Risk Factors. A Single Center ExperienceSemantic proximity Read ↗

Blood Coagulation Disorders Among the Iranian Population: a Systematic Review.Semantic proximity Read ↗

Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.Semantic proximity Read ↗

The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.Semantic proximity Read ↗

Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.Semantic proximity Read ↗

The Prevalence of Factor V Leiden (G1691A) and Methylenetetrahydrofolate Reductase C677T Mutations in Sickle Cell Disease in Western India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.